Disease variables and the proportion of patients achieving the individual component targets of MDA at 6 months (n = 167). Data are frequency (%) unless otherwise indicated.
| Variables | Values |
|---|---|
| ESR, mm/h, mean (SD) | 15.8 (16.5) |
| CRP, mg/l, mean (SD) | 8.9 (9.5) |
| PASI, mean (SD) | 3.5 (5.6) |
| BSA, % affected | 7.3 (14.3) |
| TJC, mean (SD) | 8.0 (8.9) |
| SJC, mean (SD) | 4.4 (6.4) |
| Dactylitis | 25 (15.2) |
| Enthesitis | 11 (6.6) |
| PGA, out of 10, mean (SD) | 2.2 (0.9) |
| PtGA*, mean (SD) | 2.4 (0.9) |
| Patient pain score*, mean (SD) | 4.0 (2.5) |
| HAQ, mean (SD) | 0.6 (0.6) |
| MDA, mean (SD) | 29 (17.4) |
| Tender joint count ≤ 1 | 69 (41.3) |
| Swollen joint count ≤ 1 | 97 (58.1) |
| PASI score ≤ 1 / BSA ≤ 3% | 138 (82.6) |
| Tender entheseal points ≤ 1 | 151 (90.4) |
| Patient pain score ≤ 15 | 28 (16.8) |
| Patient global disease activity ≤ 20 | 22 (13.2) |
| HAQ score ≤ 0.5 | 20 (12.0) |
↵* These were scored out of 10 and transformed into their centile equivalent for the purposes of MDA calculation. ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; PASI: Psoriasis Area Severity Index; BSA: body surface area; HAQ: Health Assessment Questionnaire; MDA: minimal disease activity; TJC: tender joint count; SJC: swollen joint count; PGA: physician’s global assessment; PtGA: patient’s global assessment.